Jan Babiak joined the Walgreen Co. board of directors in 2012 with more than 30 years of global management and board-level experience.
During a 28-year career at Ernst & Young, she held managing partner and board-level roles in the areas of technology, climate change and sustainability, and regulatory and public policy. She served in consulting, audit and assurance roles for a broad range of clients in the financial services, technology, energy, media, transportation, government, retail and other sectors.
Babiak was founder and managing partner of Ernst & Young’s fastest growing and most profitable United Kingdom practice, which provided IT security, transformation, program management and advisory and assurance services. With full P&L and operational responsibility, she grew the technology security and risk services practice in the United Kingdom, later adding Northern Europe, Middle East, India and Africa (NEMIA), for more than 10 years while also serving on Ernst & Young’s UK operating board.
Following her success in these roles, Babiak was appointed in 2006 to the NEMIA executive management board and as managing partner for regulatory and public policy in NEMIA, and was the board-level sponsor leading all services related to climate change and sustainability across the NEMIA area.
In 2008 she created a new practice as Ernst & Young’s global leader for climate change and sustainability services, operating from the firm’s London headquarters. She was responsible for the strategy and delivery of commercially focused climate change transformation and sustainability services to clients, as well as providing coordination with government offices, regulatory bodies, national professional bodies and other stakeholders. She has led teams delivering advisory, assurance, tax and transaction services focused on clean tech, renewable energy, carbon trading, environmental policy and taxation, green building, green supply chain, carbon measurement and modeling.
Babiak joined Ernst & Young’s audit practice in Oklahoma City in 1982 after earning her bachelors of business administration degree from the University of Oklahoma that same year. She later earned an MBA from Baldwin Wallace University in Ohio in 1989. She began her Ernst & Young career serving clients in the financial services, energy, retail and manufacturing industries, then transferred to its then global headquarters in Cleveland to manage the integration of technology into the firm’s audit methodology. In 1990, she transferred to London, England, initially to lead key aspects of the post-merger integration of Ernst & Whinney and Arthur Young.
She is a certified public accountant in the United States and a chartered accountant in the United Kingdom.
Babiak has served as a member of the board of directors for the Royal Mail Group since March 2013 and for the Bank of Montreal since October 2012. In 2011, she joined the governing body of the Institute of Chartered Accountants in England and Wales as a council member.
David J. Brailer, M.D., Ph.D. has served as a member of the Walgreen Co. board of directors since 2010. He has been chairman of Health Evolution Partners since 2006.
In 2004, prior to joining Health Evolution Partners, he was appointed by the Bush Administration as the first National Health Information Technology Coordinator. In that role, Brailer was the architect of a bipartisan national effort to bring the health care system into the information age, toward transparency, quality and efficiency.
Before his presidential appointment, Brailer was a senior fellow at the Health Technology Center in San Francisco, a non-profit research and education organization that provides health care organizations with strategic information and resources about the future impact of technology in health care delivery.
In 1992, Brailer founded CareScience, Inc., a spin-off from The Wharton School of Business at the University of Pennsylvania, and an early leader in the use of the Internet to share health information and improve the quality of care across the United States.
Prior to 1992, Brailer was with the University of Pennsylvania School of Medicine and The Wharton School of Business. He founded the health information technology program at The Wharton School Health Care Management Department, taught health management and economics in The Wharton MBA program and lectured in The Wharton Executive Education program. He also was an active patient-care physician in general medicine and in immune deficiency at the University of Pennsylvania.
Brailer received a bachelor’s degree in political science and his M.D. from West Virginia University. He completed his residency in internal medicine at the University Of Pennsylvania School Of Medicine and earned a Ph.D. in health economics from The Wharton School of Business, where he taught health management for a decade.
Brailer serves on the board of directors for Optimal IMX, CenseoHealth, American Optical Services, and is a member of the Health Care Policy Advisory Council at Harvard Medical School.
William C. Foote has served as a member of the Walgreen Co. board of directors since 1997. He is retired chairman and CEO of USG Corporation, the largest manufacturer of gypsum products in North America.
Foote’s assignments at USG included chairman of USG Corporation; chairman, chief executive officer and president of USG Corporation; president and CEO of USG Interiors, Inc.; president and CEO of L&W Supply Corporation; senior vice president and general manager of Central Construction Products Region, United States Gypsum Company; senior vice president, international and business development, USG Interiors, Inc.; and vice president, strategic planning, USG Corporation.
Before joining USG Corporation in 1984 as director of strategic planning and corporate development, Foote held positions of senior engagement manager at McKinsey & Company Inc. and assistant treasurer at Chase Manhattan Bank in New York.
Foote is a member of the board of directors of The Kohler Co. and a trustee of Williams College. He is also former chairman of the board of the Federal Reserve Bank of Chicago, and a life trustee of Northwestern Memorial Hospital.
Foote earned a bachelor’s degree in economics from Williams College and a master’s of business administration degree from Harvard University.
Ginger L. Graham has served as a member of the Walgreen Co. board of directors since 2010. Ginger Graham is the president and CEO of Two Trees Consulting. She consults to first-time CEO’s in the areas of leadership, strategy, board-effectiveness and organization-building.
She is the former president and chief executive officer of Amylin Pharmaceuticals, a biopharmaceutical company based in San Diego, Calif., focused on diabetes and obesity. During Ginger’s tenure at Amylin, the company launched two first-in-class medicines for people with diabetes, was listed on the Nasdaq 100 and was rated as one of the Top 10 places in the industry for scientists to work.
Prior to her time at Amylin, Ginger was group chairman, office of the president for Guidant Corporation, a major cardiovascular medical device manufacturer based in Indianapolis, Ind. During Ginger’s tenure at Guidant, the company launched the world’s leading stent platform, was listed in the Fortune 500, was recognized by Fortune Magazine as one of the Best Companies to Work For in America, and was included in Industry Week Magazine’s 100 Best Managed Companies in the World.
Ginger has received numerous awards and honors including being named as the Emerging Company Executive of the Year by the Global Health Council in 2005, a finalist in Marketwatch’s CEO of the Year in 2006, and named as the American Diabetes Association’s Woman of Valor award in 2006. She was included in Pharma VOICE’s “100 of the Most Inspiring People” list in 2006 and World Pharmaceuticals magazine named her number 10 on a list of 40 most influential people in the industry in 2007. Ginger was the first woman CEO named to the PhRMA Board and Executive Committee.
Ms. Graham also serves on the boards of directors for Genomic Health Inc. Proteus Digital Health Pharmaceutical Division, Surefire Medical, Elcelyx Therapeutics, Clovis Oncology Inc. and the Circle of Life Hospice Foundation. Ms. Graham is a member of the Harvard Business School Health Industry Alumni Advisory Board, the University of Arkansas Chancellor’s Campaign Steering Committee and the advisory board for the BioFrontiers Institute at the University of Colorado. She also serves on the advisory board for the Kellogg Center for Executive Women and co-chairs the Scientific Council of the University of Colorado’s Center for Women’s Health Research. Graham taught entrepreneurship at Harvard Business School and has written for Harvard Business Review.
Ginger received a Bachelor of Science in agricultural economics from the University of Arkansas, and holds an MBA, with distinction, from Harvard University.
Dominic Murphy has served as a member of the Walgreen Co. board of directors since August 2012, after Walgreens and Alliance Boots GmbH formed a strategic partnership to create the first global pharmacy-led, health and wellbeing enterprise.
Dominic Murphy is a partner of Kohlberg Kravis Roberts & Co. L.L.P. (KKR). He is responsible for the development of KKR’s activities in the U.K. and Ireland, is head of its healthcare industry team in Europe and is a member of the firm’s European investment and portfolio management committees. He was appointed to the board of Alliance Boots in July 2007. He is also a member of the board of Acteon, a subsea oilfield services company and Ambea, one of the largest healthcare and care services companies in the Nordic region.
Since joining KKR in 2005 he has played a significant role in the investments in Alliance Boots, Ambea, Acteon Group Ltd. and SBS Broadcasting. He also serves as a member of the Great Ormond Street Hospital’s Corporate Partnerships Board and the National Portrait Gallery Development Council. He was formerly a partner at Cinven, a large European-based private equity firm and an investment manager with 3i.
Stefano Pessina has served as a member of the Walgreen Co. board of directors since August 2012. He is executive chairman of Alliance Boots GmbH, the leading international pharmacy-led health and beauty group delivering a range of products and services to customers. He is also a non-executive director of Galenica.
Prior to the merger of Alliance UniChem and Boots Group, he was executive deputy chairman of Alliance UniChem, previously having been its chief executive for three years up until December 2004. Pessina was appointed to the Alliance UniChem Board in 1997 when UniChem merged with Alliance Santé, the Franco-Italian pharmaceutical wholesale group which he established in Italy in 1977.
Mr. Pessina is an engineer by profession.
Leonard D. Schaeffer is the Judge Robert Maclay Widney Chair and Professor at the University of Southern California in Los Angeles, California. Schaeffer former served as Chairman and Chief Executive Officer of WellPoint, Inc. (now Anthem, Inc.), then the largest health insurance company in the United States. Earlier in his career, Schaeffer worked for the federal government as Administrator of the Healthcare Care Financing Administration (now the Centers for Medicare and Medicaid Services) in the U.S. Department of Health and Human Services, with responsibility for the federal Medicare and Medicaid programs. Schaeffer currently serves as a director of Quintiles Transnational Holdings, Inc. and scPharmaceutals Inc., and also serves on the boards of the Brookings Institution, the RAND Corporation, and the University of Southern California, as well as the Board of Fellows of Harvard Medical School. Schaeffer is a member of the Institute of Medicine of the National Academy of Sciences
Nancy M. Schlichting has served as a member of the Walgreen Co. board of directors since 2006. She is chief executive officer and a member of the board of directors of Henry Ford Health System in Detroit, one of the country’s largest health care systems that integrates primary and specialty care with research and education. A 2011 recipient of the Malcolm Baldrige National Quality Award, the system includes the Henry Ford Medical Group, five owned hospitals, the Health Alliance Plan, 32 primary care centers and many other health-related entities located throughout southeastern Michigan.
Schlichting brings decades of health care expertise to Walgreens. She joined Henry Ford in 1998 as senior vice president and chief administrative officer. She was promoted to executive vice president and chief operating officer the following year and assumed the additional responsibilities of president and CEO of Henry Ford Hospital in 2001. She was formally named president and CEO of the health care system in June 2003.
Prior to joining Henry Ford Health System, Schlichting was executive vice president and chief operating officer of Summa Health System in Akron, Ohio. She has also served as president of the Eastern Region of Catholic Health Initiatives, president and CEO of Riverside Methodist Hospitals and executive vice president and chief operating officer of Akron City Hospital.
Schlichting serves on numerous community, professional and corporate boards that reflect both her professional and personal interests. She is a board member of The Kresge Foundation, the Federal Reserve Bank of Chicago – Detroit Branch, Duke University Sanford School of Public Policy Board of Visitors, the Citizen’s Research Council of Michigan, the Detroit Economic Club, the Downtown Detroit Partnership, and is past chair of the Detroit Regional Chamber.
Schlichting earned her bachelor’s degree in public policy studies magna cum laude from Duke University and a masters of business administration degree from Cornell University. She is the recipient of honorary degrees from Central Michigan University and Walsh College.
James A. Skinner was named chairman of the Walgreen Co. board of directors in July 2012 and has served as a board member since 2005. He is a retired vice chairman and chief executive officer of McDonald’s Corporation. Before being named CEO in November 2004, Skinner served as vice chairman overseeing restaurant operations in Europe, Asia, Africa and Latin America.
Skinner held numerous leadership positions during his McDonald’s career. Before becoming vice chairman, he served as president and chief operating officer of the McDonald’s Restaurant Group, with responsibility for the company’s more than 30,000 McDonald’s restaurants in 118 countries. Prior to that, Skinner was president of McDonald’s Europe.
He joined McDonald’s International management team in 1992 as senior vice president and relationship partner, overseeing McDonald’s development in Central Europe, the Middle East, Africa and India.
After serving in the United States Navy for nearly 10 years, Skinner began his career with McDonald’s in 1971 as a restaurant manager trainee in Carpentersville, Ill. He advanced quickly and held numerous positions in the U.S. company, including director of field operations, market manager, regional vice president and U.S. senior vice president/zone manager.
In addition, he has twice served as an advisory director to McDonald’s Corporation’s board of directors and currently serves on the boards of Ronald McDonald House Charities, Illinois Tool Works and Hewlett Packard.
Skinner is also a member of several civic and business organizations, including The Chicago Club, The Commercial Club of Chicago, The Economic Club of Chicago, The Executives’ Club of Chicago and The Chicago Council on Global Affairs. He also serves on the board of trustees for the Museum of Science and Industry.
You must be logged in to view this item.
Please enter the following new information, or login and update your current entry. As a registered user, you will be able to use your new ID and password immediately to access special features. When registering as an accredited media user, you will be able to access high resolution photography and media contact lists within one business day.